87 related articles for article (PubMed ID: 21492951)
21. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
22. Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases.
Weissferdt A; Moran CA
Am J Clin Pathol; 2012 Jul; 138(1):103-14. PubMed ID: 22706865
[TBL] [Abstract][Full Text] [Related]
23. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma.
Cho Y; Miyamoto M; Kato K; Fukunaga A; Shichinohe T; Kawarada Y; Hida Y; Oshikiri T; Kurokawa T; Suzuoki M; Nakakubo Y; Hiraoka K; Murakami S; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
Cancer Res; 2003 Apr; 63(7):1555-9. PubMed ID: 12670904
[TBL] [Abstract][Full Text] [Related]
24. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival.
Ino K; Yamamoto E; Shibata K; Kajiyama H; Yoshida N; Terauchi M; Nawa A; Nagasaka T; Takikawa O; Kikkawa F
Clin Cancer Res; 2008 Apr; 14(8):2310-7. PubMed ID: 18413819
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M; Melichar B; Sedláková I; Steiner I
Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
[TBL] [Abstract][Full Text] [Related]
26. Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis.
Ohno S; Ohno Y; Nakada H; Suzuki N; Soma G; Inoue M
Anticancer Res; 2006; 26(6A):4047-53. PubMed ID: 17195456
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis of surgically treated thymic epithelial tumors].
Horinouchi H; Asakura K; Kimura Y; Takeuchi K; Kawamura M; Watanabe M; Eguchi K; Kobayashi K
Nihon Geka Gakkai Zasshi; 2006 Nov; 107(6):262-7. PubMed ID: 17147284
[TBL] [Abstract][Full Text] [Related]
28. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB
J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941
[TBL] [Abstract][Full Text] [Related]
29. Difference in the distribution of tumor-infiltrating CD8+ T cells and FOXP3+ T cells between micronodular thymoma with lymphoid stroma and micronodular thymic carcinoma with lymphoid stroma.
Yagi H; Nakaguro M; Ito M; Okumura Y; Takahashi S; Aoshima Y; Enomoto Y; Meguro S; Kawasaki H; Kosugi I; Shimoyama Y; Ogawa H; Tateyama H; Iwashita T
Pathol Int; 2021 Jul; 71(7):453-462. PubMed ID: 33819365
[TBL] [Abstract][Full Text] [Related]
30. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
31. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
[TBL] [Abstract][Full Text] [Related]
32. Fas ligand expression in metastatic renal cell carcinoma during interleukin-2 based immunotherapy: no in vivo effect of Fas ligand tumor counterattack.
Donskov F; von der Maase H; Marcussen N; Hamilton-Dutoit S; Madsen HH; Jensen JJ; Hokland M
Clin Cancer Res; 2004 Dec; 10(23):7911-6. PubMed ID: 15585624
[TBL] [Abstract][Full Text] [Related]
33. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
[TBL] [Abstract][Full Text] [Related]
34. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.
Grabenbauer GG; Lahmer G; Distel L; Niedobitek G
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3355-60. PubMed ID: 16740757
[TBL] [Abstract][Full Text] [Related]
35. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
36. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Donnem T; Persson M; Bremnes RM; Busund LT
Histopathology; 2009 Sep; 55(3):301-12. PubMed ID: 19723145
[TBL] [Abstract][Full Text] [Related]
39. Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.
Ness N; Andersen S; Valkov A; Nordby Y; Donnem T; Al-Saad S; Busund LT; Bremnes RM; Richardsen E
Prostate; 2014 Oct; 74(14):1452-61. PubMed ID: 25111810
[TBL] [Abstract][Full Text] [Related]
40. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
